Glazer Capital »

ImmunoGen shares owned by Glazer Capital

Quarter-by-quarter ownership of ImmunoGen shares owned by Glazer Capital from 13F filings

Historical chart of Glazer Capital investment in ImmunoGen

Tip: Access up to 7 years of quarterly data

All positions including ImmunoGen held by Glazer Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ImmunoGen by Glazer Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.0M 271k 29.65

More positions owned by Glazer Capital

Splunk Note 1.125% 09/01 (Principal)
Alteryx Com Cl A
Spirit Rlty Cap Com New
Docusign Note 01/01 (Principal)
Western Digital Corp. Note 1.5% 2/0 (Principal)
Chico's FAS
National Westn Life Group In Cl A (NWLI)
Rover Group Com Cl A
Textainer Group Holdings SHS
Hollysys Automation Tchngy L SHS (HOLI)
Karuna Therapeutics Ord
Engagesmart Common Stock
Investcorp India Acquistn Class A Ord Shs (IVCA)
Investcorp Europe Acquisitio Class A Ord Shs (IVCB)
Rpt Realty Sh Ben Int

View all positions for Glazer Capital

Top funds holding ImmunoGen

Vanguard Group
RA Capital Management
Redmile Group
Henderson Group
Pentwater Capital Management
Fairmount Funds Management
Norges Bank Investment Management
Millennium Management
D. E. Shaw & Co
Balyasny Asset Management
Voloridge Investment Management
Boxer Capital
Maverick Capital
TIG Advisors
Tang Capital Management

View all funds holding ImmunoGen